Eiko Lifesciences Stock Price Analysis and Quick Research Report. Is Eiko Lifesciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Eiko Lifesciences. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Eiko Lifesciences has a PE ratio of 37.1242517924094 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Eiko Lifesciences has ROA of 3.078% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Eiko Lifesciences has a Current ratio of 12.5062.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Eiko Lifesciences has a ROE of 3.2507%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Eiko Lifesciences has a Debt to Equity ratio of 0.0311 which means that the company has low proportion of debt in its capital.

• Sales growth: Eiko Lifesciences has reported revenue growth of 16.3359% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Eiko Lifesciences for the current financial year is 5.28040921093937%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Eiko Lifesciences is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Eiko Lifesciences is Rs 1.5203. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Eiko Lifesciences in Ticker for free. Also, one can get the intrinsic value of Eiko Lifesciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Eiko Lifesciences FAQs

Q1. What is Eiko Lifesciences share price today?
Ans: The current share price of Eiko Lifesciences is Rs 56.44.

Q2. What is the market capitalisation of Eiko Lifesciences?
Ans: Eiko Lifesciences has a market capitalisation of Rs 77.440499976 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Eiko Lifesciences?
Ans: The PE ratio of Eiko Lifesciences is 37.1242517924094 and the P/B ratio of Eiko Lifesciences is 1.35682209379477, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Eiko Lifesciences share?
Ans: The 52-week high share price of Eiko Lifesciences is Rs 74.88, and the 52-week low share price of Eiko Lifesciences is Rs 42.

Q5. Does Eiko Lifesciences pay dividends?
Ans: Currently, Eiko Lifesciences does not pay dividends. Dividend yield of Eiko Lifesciences is around 0%.

Q6. What are the face value and book value of Eiko Lifesciences shares?
Ans: The face value of Eiko Lifesciences shares is Rs 10, while the book value per share of Eiko Lifesciences is around Rs 41.5972. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Eiko Lifesciences?
Ans: Eiko Lifesciences has a total debt of Rs 1.754 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Eiko Lifesciences?
Ans: The ROE of Eiko Lifesciences is 3.2507% and ROCE of Eiko Lifesciences is 4.5045%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Eiko Lifesciences a good buy for the long term?
Ans: The Eiko Lifesciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Eiko Lifesciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Eiko Lifesciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Eiko Lifesciences’s financials?
Ans: You can review Eiko Lifesciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.